Compugen Ltd., a clinical-stage cancer immunotherapy company using AI for drug discovery, announced its management will participate in the Stifel 2026 Healthcare Conference in New York on November 10 and the Jefferies Global Healthcare Conference in London on November 18-19. The company will present updates on its AI-powered drug discovery platform and its immuno-oncology pipeline, including therapies like COM701, rilvegostomig, and GS-0321. These events provide opportunities for investors to learn about Compugen's progress in developing novel cancer treatments and its collaborations with AstraZeneca and Gilead. A live webcast of the Stifel fireside chat will be available on Compugen's website.
Compugen's upcoming participation in November investor conferences comes as a backdrop to broader health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 19:02 WIB: out of 150 priced US health-sector stocks, 74 rose and 69 fell. Notable movers include BioNTech SE (BNTX) with a price of USD 90.10 and a 1-day change of +2.94%, Cogent Biosciences Inc. (COGT) at USD 30.58 with +2.86%, and Travere Therapeutics Inc. (TVTX) at USD 47.30 with -3.98%. Typical hold times on Pluang range from 19 to 61 days for these stocks.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
